Latest Asset Acquisition News

Bass Oil Limited reported a 20% increase in August sales revenue alongside a 3.5% rise in daily production, while progressing regulatory approval for its strategic Vanessa gas field acquisition.

Leo Lithium has announced a significant $330 million return to shareholders in 2025, following the termination of its asset acquisition strategy and a decision to monetise remaining assets.

Metal Bank Limited has completed due diligence on Hastings Technology Metals' gold assets and is set to commence drilling at the Seven Leaders prospect, marking a key step in its Western Australian gold expansion strategy.

Forrestania Resources has signed a binding agreement to acquire the Burracoppin Gold Project from Askari Metals, adding a significant JORC resource near a major WA gold mine. The deal includes cash, shares, and options, linking Forrestania to promising African exploration assets.

Metal Bank Limited has agreed to acquire Hastings Technology Metals’ Western Australian gold assets, expanding its portfolio and advancing key projects toward production.

Genesis Minerals has secured regulatory approval for Stage One mining at Tower Hill, aligning the project with its mill expansion plans and setting the stage for production in FY28.

Charger Metals NL has appointed mining veteran Bryan Dixon as CEO, signaling a strategic shift to boost exploration and shareholder value at its lithium and gold projects.

archTIS Limited has opened the retail component of a $17 million entitlement offer to support its acquisition of Spirion LLC’s assets, aiming to expand its US footprint and enhance its cybersecurity product suite.

Nanoveu Limited’s transformative half-year report highlights its EMASS acquisition, executive hires, and technology advances amid a $3 million loss and new US OTCQB listing.

DGL Group reported a modest revenue rise but faced a significant earnings dip in FY25, driven by losses in its Environmental division and restructuring costs. The company is now focusing on integration and operational efficiencies to rebound in FY26.

Echelon Resources Limited reported a robust financial year ending June 2025, driven by strategic asset acquisitions and strong commodity prices, delivering a 34% revenue increase and a near 20-fold jump in net profit after tax.

NeuroScientific Biopharmaceuticals reported a $1.85 million loss for FY25, driven by reduced R&D incentives and increased development costs following its acquisition of StemSmart™ technology. The company is advancing clinical programs, including a Special Access Scheme for Crohn’s disease.